NIHR Invention for Innovation (i4i): PDA Call 30

i4i Product Development Awards (PDA) support collaborative research and development of medical devices, in vitro diagnostic devices and high-impact patient-focused digital health technologies for use in the NHS or social care system. PDA aims to de-risk innovations, supporting early product development and real-world evaluation, to make them more attractive for follow-on funding or commercial investment. Research proposals may address any area of unmet need. Projects must have a clear pathway towards adoption and commercialisation.

DATES:

Competition opens: 9th April 2025

Stage 1 submission deadline: 28th May 2025, 1pm

Stage 2 submission deadline (if invited): 23rd September 2025, 1pm

Applicants notified: December 2025

SCOPE – proposals must involve one of the following:

  • Medical devices or in vitro diagnostic devices as defined by the Medical Device Regulations 2002.
  • Digital health technologies that fall under Tier C of the NICE Evidence Standards Framework for Digital Health Technologies and are focused on patient outcomes and intended for ultimate use in the NHS or social care system.
  • Non-regulated digital technologies will only be considered for real-world evaluations if they have a potential application as products in the NHS or social care systems.
  • Artificial Intelligence regulated as a medical device.

PDA will support various activities, including the development of innovative technologies, preclinical and clinical trials, gathering evidence for regulatory approval, and conducting follow-up studies. A strong element of patient and public involvement and end user engagement is a prerequisite for PDA. Proposals must also set out a commercial strategy that takes into account the regulatory pathway, IP management, commercial barriers, health economics and route to market. A plan for future adoption of the technology into the NHS or social care system should be presented.

PROJECTS THAT WILL NOT BE FUNDED

  • Early stage or fundamental research
  • Projects that involve work on animals or animal tissue
  • Minor or incremental changes to technologies or interventions in current clinical use
  • Projects involving small molecule drugs, stem cells or cosmetic products
  • Scale-up manufacture of the product needed to carry out a clinical evaluation
  • Evaluation of a fully developed product, already adopted within the NHS or social care system
  • Professional training, including PhD fees and stipends (costed time of the individual is allowed)
  • Digital health technologies that fall under Tier A and Tier B of the NICE Evidence Standards Framework for Digital Health Technologies.

ELIGIBILITY

  • The lead organisation must be a UK-based NHS or social care provider, SME, Higher Education Institute (including universities and research institutes) or not-for-profit organisation.
  • Projects must be collaborative and involved at least two organisations.

FUNDING RATES

  • No maximum funding
  • Projects can be up to 36 months duration
  • 100% of direct costs funded

HOW PNO CAN SUPPORT YOU

The UK team has a strong track record in securing funding through some of the most competitive national and European grants on behalf of its clients, with a full understanding of how a project should be presented to stand the highest chance of success. Each year in the UK alone, we are responsible for the submission of more than 100 funding applications across all sectors and priority areas. Based on this extensive experience, through careful project selection and using key insight into how a project should be best positioned, we consistently achieve success rates that are more than 5 times the typical success rates for UK and EU programmes.

 

For further information or to discuss a project idea please contact PNO Consultants

0161 488 3488 | info.uk@pnoconsultants.com/https://www.pnoconsultants.com/uk/

Contact us for further information







     privacy statement is applicable